226 related articles for article (PubMed ID: 21519243)
1. New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia.
Issa GC; Leblebjian H; Roccaro AM; Ghobrial IM
Curr Opin Hematol; 2011 Jul; 18(4):260-5. PubMed ID: 21519243
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
3. Current treatment options for Waldenström macroglobulinemia.
Vijay A; Gertz MA
Clin Lymphoma Myeloma; 2008 Aug; 8(4):219-29. PubMed ID: 18765309
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow microenvironment in Waldenström macroglobulinemia.
Agarwal A; Ghobrial IM
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):218-21. PubMed ID: 23490994
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow niche in Waldenström's macroglobulinemia.
Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa G; Roccaro A
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):118-20. PubMed ID: 21454209
[TBL] [Abstract][Full Text] [Related]
6. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
Henry T; Fonseca R
Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
[TBL] [Abstract][Full Text] [Related]
7. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
8. Waldenström macroglobulinemia.
Kasi PM; Ansell SM; Gertz MA
Clin Adv Hematol Oncol; 2015 Jan; 13(1):56-66. PubMed ID: 25679974
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology.
Sacco A; Issa GC; Zhang Y; Liu Y; Maiso P; Ghobrial IM; Roccaro AM
J Hematol Oncol; 2010 Oct; 3():38. PubMed ID: 20929526
[TBL] [Abstract][Full Text] [Related]
10. Novel treatment options for Waldenström macroglobulinemia.
Leblebjian H; Agarwal A; Ghobrial I
Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2(0 2):S310-6. PubMed ID: 24290218
[TBL] [Abstract][Full Text] [Related]
11. Waldenström macroglobulinemia: from biology to treatment.
Sahin I; Leblebjian H; Treon SP; Ghobrial IM
Expert Rev Hematol; 2014 Feb; 7(1):157-68. PubMed ID: 24405328
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia.
Kyriakou C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):865-874. PubMed ID: 30190024
[TBL] [Abstract][Full Text] [Related]
13. Macroglobulinemia--a review.
Waldenström JG
Haematologica; 1986; 71(6):437-40. PubMed ID: 3104150
[No Abstract] [Full Text] [Related]
14. Genomic Landscape of Waldenström Macroglobulinemia.
Treon SP; Xu L; Liu X; Hunter ZR; Yang G; Castillo JJ
Hematol Oncol Clin North Am; 2018 Oct; 32(5):745-752. PubMed ID: 30190014
[TBL] [Abstract][Full Text] [Related]
15. Targeting the bone marrow in Waldenstrom macroglobulinemia.
Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa GC; Leleu X; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S65-9. PubMed ID: 22035751
[TBL] [Abstract][Full Text] [Related]
16. [Waldenstrom's macroglobulinemia].
Sáenz de Santa María J; Bueno Jiménez C; Elduayen Izaguerri R; Díaz Rodríguez E; Fernández-Cavada Caloca JP; Brull Sabate JM; Pérez Miranda M
Rev Clin Esp; 1984 Jan; 172(1):1-3. PubMed ID: 6424186
[No Abstract] [Full Text] [Related]
17. Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.
Manasanch EE; Kristinsson SY; Landgren O
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):194-7. PubMed ID: 23473950
[TBL] [Abstract][Full Text] [Related]
18. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with inv(16)(p13q22) as a sole genetic abnormality.
Frater JL; Mirkhaef M; Batanian JR
Cancer Genet Cytogenet; 2007 Apr; 174(2):161-5. PubMed ID: 17452259
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations of Waldenström macroglobulinemia.
Baehring JM; Hochberg EP; Raje N; Ulrickson M; Hochberg FH
Nat Clin Pract Neurol; 2008 Oct; 4(10):547-56. PubMed ID: 18813229
[TBL] [Abstract][Full Text] [Related]
20. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
Boutilier AJ; Huang L; Elsawa SF
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
